Log in

Revance Therapeutics News Headlines (NASDAQ:RVNC)

$12.18
+0.52 (+4.46 %)
(As of 10/13/2019 04:00 PM ET)
Today's Range
$11.80
Now: $12.18
$12.43
50-Day Range
$10.37
MA: $12.22
$14.44
52-Week Range
$9.88
Now: $12.18
$26.89
Volume201,825 shs
Average Volume343,625 shs
Market Capitalization$537.14 million
P/E RatioN/A
Dividend YieldN/A
Beta1.14

Headlines

Revance Therapeutics (NASDAQ RVNC) News Headlines

Source:
DateHeadline
Were Hopeful That Revance Therapeutics (NASDAQ:RVNC) Will Use Its Cash WiselyWe're Hopeful That Revance Therapeutics (NASDAQ:RVNC) Will Use Its Cash Wisely
finance.yahoo.com - October 8 at 10:18 PM
We're Hopeful That Revance Therapeutics (NASDAQ:RVNC) Will Use Its Cash WiselyWe're Hopeful That Revance Therapeutics (NASDAQ:RVNC) Will Use Its Cash Wisely
finance.yahoo.com - October 8 at 5:18 PM
Revance: Brace For Competition In The Botox MarketRevance: Brace For Competition In The Botox Market
seekingalpha.com - October 5 at 9:10 AM
Revance Therapeutics (RVNC) Presents At Cantor Healthcare Conference - SlideshowRevance Therapeutics (RVNC) Presents At Cantor Healthcare Conference - Slideshow
seekingalpha.com - October 3 at 8:34 PM
Revance Earns Great Place to Work® Certification for Second YearRevance Earns Great Place to Work® Certification for Second Year
finance.yahoo.com - October 2 at 4:25 PM
$400,000.00 in Sales Expected for Revance Therapeutics Inc (NASDAQ:RVNC) This Quarter$400,000.00 in Sales Expected for Revance Therapeutics Inc (NASDAQ:RVNC) This Quarter
www.americanbankingnews.com - September 30 at 2:34 AM
 Analysts Expect Revance Therapeutics Inc (NASDAQ:RVNC) to Announce -$0.89 EPS Analysts Expect Revance Therapeutics Inc (NASDAQ:RVNC) to Announce -$0.89 EPS
www.americanbankingnews.com - September 28 at 6:36 PM
Revance Therapeutics Inc (NASDAQ:RVNC) Receives Average Recommendation of "Buy" from BrokeragesRevance Therapeutics Inc (NASDAQ:RVNC) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - September 28 at 2:46 AM
Revance Therapeutics (RVNC) Presents At 2019 Wells Fargo Healthcare Conference - SlideshowRevance Therapeutics (RVNC) Presents At 2019 Wells Fargo Healthcare Conference - Slideshow
seekingalpha.com - September 6 at 1:51 PM
Revance to Participate in the Morgan Stanley 17th Annual Global Healthcare ConferenceRevance to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
finance.yahoo.com - September 5 at 12:35 PM
Revance to Participate in the Wells Fargo 14th Annual Healthcare ConferenceRevance to Participate in the Wells Fargo 14th Annual Healthcare Conference
finance.yahoo.com - August 29 at 11:26 AM
Revance extends decision timeline for Mylan for Botox biosimilarRevance extends decision timeline for Mylan for Botox biosimilar
seekingalpha.com - August 27 at 9:26 AM
Does Revance Therapeutics, Inc.'s (NASDAQ:RVNC) CEO Pay Compare Well With Peers?Does Revance Therapeutics, Inc.'s (NASDAQ:RVNC) CEO Pay Compare Well With Peers?
finance.yahoo.com - August 23 at 7:08 PM
Edited Transcript of RVNC earnings conference call or presentation 5-Aug-19 8:30pm GMTEdited Transcript of RVNC earnings conference call or presentation 5-Aug-19 8:30pm GMT
finance.yahoo.com - August 6 at 7:46 PM
Revance Reports Second Quarter 2019 Financial Results, Provides Corporate UpdateRevance Reports Second Quarter 2019 Financial Results, Provides Corporate Update
finance.yahoo.com - August 5 at 7:42 PM
Revance to Release Second Quarter 2019 Financial Results on Monday, August 5, 2019Revance to Release Second Quarter 2019 Financial Results on Monday, August 5, 2019
finance.yahoo.com - July 29 at 8:36 PM
Will Revance Therapeutics (RVNC) Report Negative Q2 Earnings? What You Should KnowWill Revance Therapeutics (RVNC) Report Negative Q2 Earnings? What You Should Know
finance.yahoo.com - July 25 at 8:04 PM
Revance: A Wrinkle-Inducing Year Creates An OpportunityRevance: A Wrinkle-Inducing Year Creates An Opportunity
seekingalpha.com - July 18 at 9:39 AM
Revance Adds Life Sciences Audit Executive Chris Nolet to Board of DirectorsRevance Adds Life Sciences Audit Executive Chris Nolet to Board of Directors
finance.yahoo.com - July 17 at 9:15 AM
Did Changing Sentiment Drive Revance Therapeuticss (NASDAQ:RVNC) Share Price Down A Worrying 59%?Did Changing Sentiment Drive Revance Therapeutics's (NASDAQ:RVNC) Share Price Down A Worrying 59%?
finance.yahoo.com - July 9 at 6:03 PM
Did Changing Sentiment Drive Revance Therapeutics's (NASDAQ:RVNC) Share Price Down A Worrying 59%?Did Changing Sentiment Drive Revance Therapeutics's (NASDAQ:RVNC) Share Price Down A Worrying 59%?
finance.yahoo.com - July 9 at 6:03 PM
Dermavant Sciences Readies Terms For $100 Million IPODermavant Sciences Readies Terms For $100 Million IPO
seekingalpha.com - June 13 at 8:59 AM
Revance Adds Iconic Brand Builder Jill Beraud to Board of DirectorsRevance Adds Iconic Brand Builder Jill Beraud to Board of Directors
finance.yahoo.com - June 6 at 9:08 AM
Revance to Participate in the Goldman Sachs 40th Annual Global Healthcare ConferenceRevance to Participate in the Goldman Sachs 40th Annual Global Healthcare Conference
finance.yahoo.com - June 4 at 6:14 PM
Revance to Participate in the RBC Capital Markets 2019 Healthcare ConferenceRevance to Participate in the RBC Capital Markets 2019 Healthcare Conference
finance.yahoo.com - May 14 at 7:27 PM
Revance to file U.S. application for DAXI for frown lines in late Q3Revance to file U.S. application for DAXI for frown lines in late Q3
seekingalpha.com - May 9 at 7:05 PM
Revance Therapeutics (RVNC) Q1 2019 Earnings Call TranscriptRevance Therapeutics (RVNC) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 9 at 7:05 PM
Revance Therapeutics, Inc. (RVNC) on Q1 2019 Results - Earnings Call TranscriptRevance Therapeutics, Inc. (RVNC) on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 9:04 AM
Edited Transcript of RVNC earnings conference call or presentation 8-May-19 8:30pm GMTEdited Transcript of RVNC earnings conference call or presentation 8-May-19 8:30pm GMT
finance.yahoo.com - May 9 at 9:04 AM
Revance Therapeutics beats by $0.08, misses on revenueRevance Therapeutics beats by $0.08, misses on revenue
seekingalpha.com - May 8 at 7:03 PM
Revance Reports First Quarter 2019 Financial Results and Provides Corporate UpdateRevance Reports First Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - May 8 at 7:03 PM
Is Revance Therapeutics Inc (RVNC) A Good Stock To Buy?Is Revance Therapeutics Inc (RVNC) A Good Stock To Buy?
finance.yahoo.com - May 7 at 6:26 PM
Will Revance Therapeutics (RVNC) Report Negative Earnings Next Week? What You Should KnowWill Revance Therapeutics (RVNC) Report Negative Earnings Next Week? What You Should Know
finance.yahoo.com - May 1 at 6:54 PM
A Spotlight On Revance Therapeutics, Inc.'s (NASDAQ:RVNC) FundamentalsA Spotlight On Revance Therapeutics, Inc.'s (NASDAQ:RVNC) Fundamentals
finance.yahoo.com - May 1 at 6:54 PM
Revance to Release First Quarter 2019 Financial Results on Wednesday, May 8, 2019Revance to Release First Quarter 2019 Financial Results on Wednesday, May 8, 2019
finance.yahoo.com - April 24 at 5:58 PM
Revance Appoints Former Allergan Marketing Veteran Taryn Conway as Vice President of MarketingRevance Appoints Former Allergan Marketing Veteran Taryn Conway as Vice President of Marketing
finance.yahoo.com - April 9 at 9:28 AM
Does Revance Therapeutics, Inc. (NASDAQ:RVNC) Have A Volatile Share Price?Does Revance Therapeutics, Inc. (NASDAQ:RVNC) Have A Volatile Share Price?
finance.yahoo.com - April 1 at 7:07 PM
Edited Transcript of RVNC earnings conference call or presentation 26-Feb-19 9:30pm GMTEdited Transcript of RVNC earnings conference call or presentation 26-Feb-19 9:30pm GMT
finance.yahoo.com - February 27 at 9:06 AM
Revance Therapeutics Inc (RVNC) Q4 2018 Earnings Conference Call TranscriptRevance Therapeutics Inc (RVNC) Q4 2018 Earnings Conference Call Transcript
www.fool.com - February 26 at 9:18 PM
Revance Releases Fourth Quarter and Full Year 2018 ResultsRevance Releases Fourth Quarter and Full Year 2018 Results
finance.yahoo.com - February 26 at 6:08 PM
Revance to Release Fourth Quarter and Full Year 2018 Financial Results on Tuesday, February 26, 2019Revance to Release Fourth Quarter and Full Year 2018 Financial Results on Tuesday, February 26, 2019
finance.yahoo.com - February 12 at 6:05 PM
CohBar Announces the Appointment of Dr. Phyllis Gardner to its Board of DirectorsCohBar Announces the Appointment of Dr. Phyllis Gardner to its Board of Directors
finance.yahoo.com - February 11 at 10:12 AM
United States : Revance Therapeutics, Inc. $115 Million Common Stock OfferingUnited States : Revance Therapeutics, Inc. $115 Million Common Stock Offering
www.marketwatch.com - January 30 at 6:24 PM
What Kind Of Shareholders Own Revance Therapeutics, Inc. (NASDAQ:RVNC)?What Kind Of Shareholders Own Revance Therapeutics, Inc. (NASDAQ:RVNC)?
finance.yahoo.com - January 28 at 5:46 PM
Sri Lanka : Revance Therapeutics, Inc. $115 Million Common Stock OfferingSri Lanka : Revance Therapeutics, Inc. $115 Million Common Stock Offering
www.marketwatch.com - January 24 at 5:56 PM
Form 424B5 Revance Therapeutics, - StreetInsider.comForm 424B5 Revance Therapeutics, - StreetInsider.com
www.streetinsider.com - January 18 at 6:56 PM
Revance prices stock offeringRevance prices stock offering
seekingalpha.com - January 17 at 9:32 AM
Revance Trumpets Stock OfferingRevance Trumpets Stock Offering
www.baystreet.ca - January 16 at 5:24 PM
Revance Announces Ground-Breaking Data Presentations at Leading International Neurotoxin ConferenceRevance Announces Ground-Breaking Data Presentations at Leading International Neurotoxin Conference
finance.yahoo.com - January 15 at 8:59 AM
Revance on recent regulatory progress and provides anticipated 2019 milestonesRevance on recent regulatory progress and provides anticipated 2019 milestones
seekingalpha.com - January 8 at 9:04 AM
This page was last updated on 10/13/2019 by MarketBeat.com Staff

Featured Article: Earnings Per Share

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel